RecruitingNot applicableNCT07576595
Official study title

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Study summary

This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.

Ask AI to explain this study
Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedSmoking cessation multilevel Intervention

The study team can explain what participation involves.

Who it may be forLung Cancer Screening · Tobacco Use Disorder

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 11, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Louisiana State University Health Sciences Center in New Orleans

Study sponsor

01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Not applicable
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Interventions being studied
Behavioral: Smoking cessation multilevel Intervention
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • African American
  • 20+ pack years of smoking
  • eligible for or received LDCT screening
  • current smoker
  • English speaking
Reasons someone may not be able to joinExclusion criteria

N/A

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • LSUHSC School of Public HealthNew Orleans, Louisiana
  • University Medical CenterNew Orleans, Louisiana

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 11, 2026. Always confirm current availability with the study team.

View original record ↗